Trials / Completed
CompletedNCT04974229
Prognostic Factor Research of Sensory Profiles in Development of Central Sensitization
Sensory Profiles as Predictors of Central Sensitization in Low Back Pain: A Prospective Cohort Study.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 102 (actual)
- Sponsor
- Vrije Universiteit Brussel · Academic / Other
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
A longitudinal observational cohort study to investigate the value of prognostic factors, here sensory profiles , and others, in the development of central sensitization in the low back pain population. A type 2 prognostic factor research following the PROGRESS framework. Sensory profiles are identified a prognostic factors which can predict the development of central sensitization in the low back pain population.
Detailed description
After performing an univariable linear regression analyses the regression model predicts the dependent variable, central sensitization, significantly, and the models are significant prediction factors of the development of central sensitization. In unadjusted analyses, all four sensory profiles were significantly associated with the development of central sensitization (P\<0.001). After adjusting for pain, disability, age, and duration of low back pain, baseline sensory profiles remained significant predictors of central sensitization. On the other hand, all other predictor variables did not contribute to the prediction of central sensitization.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | In line with the Dutch guideline for non-specific low back pain, Standard usual care for non-specific low back pain was applied. | In line with the Dutch guideline for non-specific low back pain, Standard usual care or non-specific low back pain was applied. |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2017-03-01
- Completion
- 2017-03-01
- First posted
- 2021-07-23
- Last updated
- 2021-07-23
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT04974229. Inclusion in this directory is not an endorsement.